Arkolith/Insider Trading/MLYS/Form 4

Rodman David Malcom

Chief Medical OfficerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Jul 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$557K
Net Open-Market Flow
-$557K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Sell(S)6K$26.61$169K51K
Jul 13, 2026Option exercise(M)4K$14.25$59K65K
Jul 13, 2026Option exercise(M)6K$1.08$7K72K
Jul 13, 2026Sell(S)14K$27.58$388K58K
Jul 13, 2026Option exercise(M)4K$10.20$36K61K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)4K—$0110K
Jul 13, 2026Option exercise(M)4K—$079K
Jul 13, 2026Option exercise(M)6K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001933414-26-000099) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML